Cellectar Biosciences, Inc. 10-Q

Item 5. Other Information N o n e . ​ 36 Table of Contents Item 6. Exhibits ​ Incorporation by Reference Exhibit No. Description Filed with this Form 10-Q Form Filing Date Exhibit No. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 10.1 ​ Form of Common Warrant ​ ​ ​ S-1/A ​ June 30, 2025 ​ 4.2 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 10.2 ​ Form of Pre-Funded Warrant ​ ​ ​ S-1/A ​ June 30, 2025 ​ 4.3 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 10.3 ​ Form of Representative Warrant ​ ​ ​ S-1/A ​ June 30, 2025 ​ 4.4 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 10.4 ​ Form of Warrant Agency Agreement ​ ​ ​ S-1/A ​ June 30, 2025 ​ 4.5 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 10.5 ​ Inducement Letter in consideration for Exercise of the Common Stock Purchase Warrants issued on October 25, 2022, July 21, 2024 and July 2, 2025 ​ ​ ​ 8-K ​ October 10, 2025 ​ 10.1 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 10.6 ​ Form of Series I Common Stock Purchase Warrant ​ ​ ​ 8-K ​ October 10, 2025 ​ 4.1 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 10.7 ​ Form of Series II Common Stock Purchase Warrant ​ ​ ​ 8-K ​ October 10, 2025 ​ 4.2 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 3.1 31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 101 Interactive Data Files X 104 ​ Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit). ​ X ​ ​ ​ ​ ​ ​ ​ ​ 37 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ​ CELLECTAR BIOSCIENCES, INC. Date: November 13, 2025 By: /s/ James V. Caruso James V. Caruso President and Chief Executive Officer ​ ​ (Principal Executive Officer) ​ ​ ​ Date: November 13, 2025 By: /s/ Chad J. Kolean ​ ​ Chad J. Kolean ​ ​ Chief Financial Officer ​ ​ (Principal Financial and Accounting Officer) ​ ​ 38